Depression and Menopause: An Update on Current Knowledge and Clinical Management for this Critical Window.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31078198.
- Also identified by DOI 10.1016/j.mcna.2019.03.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Windows of vulnerability for depression have been associated with increased sensitivity to hormonal changes experienced by some women during the luteal phase, postpartum, and/or menopause. Increased awareness has resulted in greater adoption of screening tools for mood and behavioral changes and tailored therapies. This article discusses study results and controversies surrounding therapies uniquely designed for menopause-related depression.
Medical subject headings
- Antidepressive Agents
- Estrogen Replacement Therapy
- Menopause
- Mood Disorders